BioInvest In The News

Life Sciences Report (12-30-14)
Dash of Insight (11-16-14)
Biotech Watchlist Update (11-6-14)
MoneyShow Biotech Bets (11-3-14)
Five Prime: A Prime Play on Proteins (9-22-14)
U~T San Diego Isis Pharmaceuticals (9-3-14)
Company Updates
'Access to Management' Conference Call with Novavax 12-19-14

‘Access to Management’ Conference Call with Novavax 12-19-14

(for subscribers only) Listen to the ‘Access to Management’ Conference Call we had with the Novavax Management Team on Friday, December 19, 2014 where we discussed what’s in the Novavax pipeline, offered a brief R&D Summary and had a Q&A session with subscribers.        

Isis Update (12-9-2014)

Isis Update (12-9-2014)

Special ASH Update for ISIS ISIS Factor XI Data Published in NEJM, 2nd Time in One Week:  Isis has been an unexpected star at ASH as they have released the final Phase II data for ISIS-FXI at ASH and were also published in the New England Medical Journal.  The data showed a significant reduction (seven-fold [...]

Pharmacyclics Update (9-10-14)

Pharmacyclics Update (9-10-14)

Special Update – PCYC Scores VA Contract, PCYC Shares Still Undervalued – In breaking news, PCYC has been awarded a large Veterans Affairs (VA) contract for Imbruvica.   Details – VA – A Large Buying Group: The following information was posted today (dated September 4, 2014)   Solicitation Number: VA797P14R0033 Contract Award Date: September 4, [...]